Elixirgen Therapeutics, Inc.
Clinical trials sponsored by Elixirgen Therapeutics, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Experimental infusion aims to fix bone marrow failure in rare telomere disease Results expected Oct 2026 (estimated)